Skip to content
10-Q

Quarterly Report

Structure Therapeutics Inc. GPCR

0001104659-25-107829

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 182.03M sh
Shares Diluted Q3 2025 · Sep 30, 2025 175.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 173.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 171.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 153.26M sh
Capex Q3 2025 · Sep 30, 2025 $2.12M
Capex Q3 2025 · Sep 30, 2024 $1.27M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$157.78M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$80.17M
Short Term Investments Q3 2025 · Sep 30, 2025 $696.13M
Short Term Investments Q3 2025 · Dec 31, 2024 $714.01M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $102.91M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $169.51M
Stockholders Equity Q3 2025 · Sep 30, 2025 $770.02M
Stockholders Equity Q3 2025 · Jun 30, 2025 $772.08M
Stockholders Equity Q3 2025 · Mar 31, 2025 $824.64M
Stockholders Equity Q3 2025 · Dec 31, 2024 $864.84M
Stockholders Equity Q3 2025 · Sep 30, 2024 $896.8M
Stockholders Equity Q3 2025 · Jun 30, 2024 $921.03M
Stockholders Equity Q3 2025 · Mar 31, 2024 $429.82M
Stockholders Equity Q3 2025 · Dec 31, 2023 $452.97M
Current Liabilities Q3 2025 · Sep 30, 2025 $57.53M
Current Liabilities Q3 2025 · Dec 31, 2024 $36.02M
Total Liabilities Q3 2025 · Sep 30, 2025 $62.14M
Total Liabilities Q3 2025 · Dec 31, 2024 $38.49M
Current Assets Q3 2025 · Sep 30, 2025 $814.02M
Current Assets Q3 2025 · Dec 31, 2024 $891.21M
Total Assets Q3 2025 · Sep 30, 2025 $832.16M
Total Assets Q3 2025 · Dec 31, 2024 $903.33M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.20
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.56
Eps Basic Q3 2025 · Sep 30, 2025 −$0.37
Eps Basic Q3 2025 · Sep 30, 2025 −$1.00
Eps Basic Q3 2025 · Sep 30, 2024 −$0.20
Eps Basic Q3 2025 · Sep 30, 2024 −$0.56
Sga Expense Q3 2025 · Sep 30, 2025 $14.8M
Sga Expense Q3 2025 · Sep 30, 2025 $43.98M
Sga Expense Q3 2025 · Sep 30, 2024 $13.24M
Sga Expense Q3 2025 · Sep 30, 2024 $35.84M
Rd Expense Q3 2025 · Sep 30, 2025 $58.99M
Rd Expense Q3 2025 · Sep 30, 2025 $156.57M
Rd Expense Q3 2025 · Sep 30, 2024 $32.6M
Rd Expense Q3 2025 · Sep 30, 2024 $75.33M
Net Income Q3 2025 · Sep 30, 2025 −$65.71M
Net Income Q3 2025 · Sep 30, 2025 −$174.21M
Net Income Q3 2025 · Jun 30, 2025 −$61.66M
Net Income Q3 2025 · Mar 31, 2025 −$46.83M
Net Income Q3 2025 · Sep 30, 2024 −$33.98M
Net Income Q3 2025 · Sep 30, 2024 −$86.05M
Net Income Q3 2025 · Jun 30, 2024 −$26.03M
Net Income Q3 2025 · Mar 31, 2024 −$26.04M
Operating Income Q3 2025 · Sep 30, 2025 −$73.79M
Operating Income Q3 2025 · Sep 30, 2025 −$200.55M
Operating Income Q3 2025 · Sep 30, 2024 −$45.84M
Operating Income Q3 2025 · Sep 30, 2024 −$111.17M